Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 08 - 11 tags : Therapeutics save search
Nabriva Therapeutics Completes Patient Enrollment in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis
Published: 2022-08-11 (Crawled : 14:20) - globenewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 2.74%
H: 10.14%
C: -0.87%
xenleta fibrosis trial therapeutics
Onconova Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-11 (Crawled : 14:20) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: 0.94%
H: 1.31%
C: 0.75%
business update therapeutics financial results
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-11 (Crawled : 14:25) - ir.agiletherapeutics.com
AGRX | $0.37 0.0% 95K
|
Health Technology
|
| O: -4.91%
H: 0.0%
C: -7.38%
therapeutics financial update results
Marker Therapeutics Reports Q2 2022 Operating and Financial Results
Published: 2022-08-11 (Crawled : 01:00) - biospace.com/
MRKR | $4.425 5.42% 10K
|
Consumer Services
|
| O: 3.36%
H: 0.0%
C: -11.06%
therapeutics results
Regulus Therapeutics Reports Second Quarter 2022 Financial Results and Recent Updates
Published: 2022-08-11 (Crawled : 22:00) - biospace.com/
RGLS | $2.23 -1.33% -1.35% 92K
|
Health Technology
|
| O: 4.12%
H: 1.13%
C: -6.78%
therapeutics results
Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-11 (Crawled : 22:00) - biospace.com/
LCTX | $1.1 -3.51% 0.0% 740K
|
Health Technology
|
| O: 0.64%
H: 4.46%
C: -1.27%
therapeutics update results
VistaGen Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
Published: 2022-08-11 (Crawled : 22:00) - biospace.com/
VTGN | $4.75 -1.66% -1.68% 150K
|
Health Technology
|
| O: 0.41%
H: 9.27%
C: 1.98%
therapeutics update results
Nabriva Therapeutics Completes Patient Enrollment in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis- Topline Data Expected First Quarter 2023 -
Published: 2022-08-11 (Crawled : 16:00) - biospace.com/
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 2.74%
H: 10.14%
C: -0.87%
xenleta topline expected trial therapeutics cystic fibrosis phase 1
Entrada Therapeutics Reports Second Quarter 2022 Financial Results
Published: 2022-08-11 (Crawled : 16:00) - biospace.com/
TRDA | $12.54 -2.72% -2.79% 39K
|
Professional, Scientific, and T...
|
| O: 8.8%
H: 0.0%
C: -7.43%
therapeutics results
Viracta Therapeutics Appoints Jane Chung, R.Ph., to its Board of Directors
Published: 2022-08-11 (Crawled : 16:00) - biospace.com/
VIRX | $0.8367 -1.31% -1.33% 55K
|
Manufacturing
|
| O: 7.32%
H: 2.17%
C: 1.77%
therapeutics
F-star Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
Published: 2022-08-11 (Crawled : 14:00) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: -1.06%
H: 1.22%
C: 0.31%
therapeutics results
Monte Rosa Therapeutics Reports Second Quarter 2022 Financial Results and Business Updates
Published: 2022-08-11 (Crawled : 14:00) - biospace.com/
GLUE | $5.46 -1.44% -1.47% 83K
|
Professional, Scientific, and T...
|
| O: 8.38%
H: 0.0%
C: -2.97%
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 1.23%
H: 0.96%
C: 0.24%
rosa therapeutics results
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022
Published: 2022-08-11 (Crawled : 13:00) - biospace.com/
SMMT | $3.605 -3.35% -3.47% 1.3M
|
Health Technology
|
| O: 1.92%
H: 5.66%
C: 2.83%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 1.44%
H: 2.85%
C: 0.61%
therapeutics
RAPT Therapeutics Reports Second Quarter 2022 Financial ResultsCompany maintains strong cash position of $207.3 million
Published: 2022-08-11 (Crawled : 13:00) - biospace.com/
RAPT | $7.905 -1.19% -1.2% 290K
|
Health Technology
|
| O: 0.89%
H: 7.21%
C: 2.14%
therapeutics
NeuBase Therapeutics Reports Business Update and Financial Results for the Third Quarter of Fiscal Year 2022
Published: 2022-08-11 (Crawled : 13:00) - biospace.com/
NBSE | $0.421 4.52% 21K
|
Health Technology
|
| O: 2.56%
H: 0.0%
C: -5.0%
year therapeutics update
Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis
Published: 2022-08-11 (Crawled : 13:00) - biospace.com/
KTTA | $7.09 -1.19% 910
|
|
| O: 17.08%
H: 7.3%
C: -8.76%
preclinical vaccine therapeutics results sclerosis study multiple sclerosis
Werewolf Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights
Published: 2022-08-11 (Crawled : 12:20) - biospace.com/
HOWL | $6.405 -0.54% -0.55% 82K
|
Professional, Scientific, and T...
|
| O: 1.67%
H: 14.81%
C: 12.14%
therapeutics results
Aptevo Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
Published: 2022-08-11 (Crawled : 12:20) - biospace.com/
APVO | $0.6827 -7.27% -7.84% 570K
|
Health Technology
|
| O: 0.45%
H: 3.53%
C: -2.22%
therapeutics results
Monopar Therapeutics Reports Second Quarter 2022 Financial Results and Recent Program Developments
Published: 2022-08-11 (Crawled : 12:20) - globenewswire.com
MNPR | $0.63 -3.08% -3.17% 39K
|
Health Technology
|
| O: -0.82%
H: 20.99%
C: 1.1%
program therapeutics results
Abeona Therapeutics Reports Second Quarter 2022 Financial Results
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
RARE F | $44.26 -1.88% -1.92% 670K
|
Health Technology
|
| O: -0.17%
H: 1.44%
C: -1.57%
ABEO | News | $3.165 -7.19% -7.74% 2.2M
|
Health Technology
|
| O: -4.57%
H: 33.25%
C: 17.38%
therapeutics results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.